Arginase Inhibition in Ischemia-reperfusion Injury

NCT02009527 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Type 2 Diabetes Mellitus

Interventions

DRUG: N-hydroxy-nor-arginine
DRUG: NaCl

Sponsor

Karolinska Institutet